Graft-Versus-Host Disease (GVHD)

Graft-versus-host disease (GvHD) is a complication that may occur during the post-transplant period in children who receive marrow stem cells from relatives including histocompatible (HLA) matched siblings and parents, as well as those who receive marrow from unrelated donors.

GvHD reactions can occur when cells of the donor's immune system, called T lymphocytes, are infused via a blood or platelet transfusion or a bone marrow transplant into the recipient, who has received conditioning therapy. Blood and platelets are irradiated to prevent GvHD, but the donor graft cannot be treated this way since irradiation also would kill the normal bone marrow stem cells.

Types and Manifestations

GvHD can take two forms, acute and chronic:

Acute GvHD usually develops within three months of the transplant and occurs in 20 percent to 25 percent of HLA-matched sibling transplants in children and 30 percent to 35 percent in adults. Acute GvHD is more common in patients undergoing unrelated transplants, in particular if there is an HLA-mismatch.
Chronic GvHD usually develops three to 18 months after the transplant and occurs in approximately 30 percent of HLA matched sibling transplants.

Patients who get acute GvHD have a 50 percent chance of developing chronic GvHD. Both types often affect the:

Eyes, causing conjunctivitis, dryness and irritation, itching
Skin, causing rash and itching
Liver, causing jaundice and/or hepatitis
Stomach and intestinal tract, resulting in loss of appetite, cramping pain, diarrhea and vomiting

Sometimes other organs of the body, including the lungs and kidneys, also are affected. A biopsy of the affected organ is often needed to confirm the diagnosis.

GvHD can be very mild or extremely severe. There is a 10 percent to 20 percent chance of dying from GvHD. When GvHD occurs in recipients of HLA-matched sibling transplants it is usually less severe and more responsive to treatment than when it occurs following a mismatched or unrelated donor transplant.

Prevention and Treatment

There are several medications that are used to help reduce the occurrence and severity of GvHD as well as to treat it when it does occur. Two drugs that are used frequently to help minimize the reaction are methotrexate and cyclosporin A. These drugs may be given singly or in combination depending upon the type of transplant and the disease. Like all drugs, these medications may have side effects including kidney and liver injury.

Drugs which may be used to treat a reaction once it occurs include steroids, such as prednisone or methylprednisilone, cyclosporin A and anti-thymocyte globulin (ATG). In addition, there are several experimental drugs that may be offered if these standard therapies are ineffective.

In a mismatched bone marrow stem cell transplant, stem cell enrichment and T cell depletion eliminate the majority of those T lymphocytes responsible for GvHD, reducing the risk of a serious reaction to an acceptable level. Depending on the type of depletion that is done and the patient's disease, methotrexate and cyclosporin A may not be needed.

UCSF Benioff Children's Hospitals medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your child's doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your child's provider.

Recommended reading

What Is Bone Marrow?

Bone marrow makes stem cells, which produce platelets and white and red blood cells. Here's why those cells are important to your child's health.

The Hospital Stay After a Pediatric Bone Marrow Transplant

Find out how long your child is likely to be in the hospital after a transplant, how to plan your stay, and how siblings can participate in the experience.

The Pediatric Bone Marrow Transplant (BMT) Decision

Learn how the bone marrow transplant (BMT) decision is made, from initial consultation to pre-transplant work-up and evaluation.

Admission to the Pediatric Bone Marrow Transplant Unit

Kids spend days in the hospital prepping for a bone marrow transplant and then stay six to eight weeks in a special room with purified air. Find out more.

On the Day of a Pediatric Bone Marrow Transplant (BMT)

Find out what happens on the day of the BMT, including the various ways donated bone marrow stem cells may be collected and given to your child.

After a Bone Marrow Transplant (BMT)

A bone marrow transplant puts kids at high risk for infection. See the possible side effects and how we help them stay as safe and comfortable as possible.

Leaving the Hospital After a Bone Marrow Transplant (BMT)

After a BMT, kids need to reach certain milestones, like being infection-free, and parents must learn to perform at-home care tasks. Here's what to expect.

Conditioning Regimen for a Bone Marrow Transplant (BMT)

Getting ready for a bone marrow transplant (BMT) may include chemotherapy and radiation. Learn how it helps and the specific drugs your child may receive.

Emotional Aspects of a Bone Marrow Transplant (BMT)

Read about typical feelings and concerns in families when a child needs a bone marrow transplant. Learn coping strategies and how to navigate challenges.

Types of Pediatric Bone Marrow Transplant (BMT) Donors

There are several types of bone marrow transplant (BMT) donors: optimal, partially matched, autologous and alternative. See the pros and cons of each.